616.234.5000
Learn More
The olfactory bulb as the entry site for prion-like propagation in
neurodegenerative diseases
Learn More

Diabetes drug slows experimental Parkinson’s disease progression,
human trials to begin next year

 

TRANSLATIONAL PARKINSON’S DISEASE RESEARCH

Patrik Brundin Laboratory
Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit
to patients and their caregivers.

Learn More

Facebook

We’re a week away from Grand Challenges in Parkinson’s Disease and Rallying to the Challenge! Don’t forget about our Facebook Live discussion on Thursday, Sept. 28 at 12:30 p.m. EST right here on the Grand Challenges Facebook page. Our panelists will address some of the biggest topics at this year’s Rallying meeting, including the latest research and recent clinical trial results. ... See MoreSee Less

View on Facebook

Can’t make it to Rallying to the Challenge this year? We have you covered. Join us at 12:30 p.m. on Thursday, Sept. 28 right here on the Grand Challenges in Parkinson’s Disease page for a Facebook Live panel that will tackle the latest research, drug repurposing and recent clinical trial findings. ... See MoreSee Less

View on Facebook

Tomorrow is the last day to register for Grand Challenges in Parkinson's Disease and Rallying to the Challenge! Sign up at www.grandchallengesinpd.org! ... See MoreSee Less

We've extended registration for Grand Challenges in Parkinson's Disease and Rallying to the Challenge through Friday, Sept. 15! Learn more and register at www.grandchallengesinpd.org.

View on Facebook